Asian equities were mostly higher overnight as Mainland China and Hong Kong outperformed and Indonesia and Thailand ...

A PAT roadmap should address data analysis, aggregation, visualization, and the smart utility of those data for greater process understanding.

WuXi AppTec Co. and WuXi Biologics Cayman Inc. said they see a brighter 2025 for the Chinese biotech and drug companies after the US Biosecure legislation that threatened to cut them out from ...

WuXi Biologics agreed to sell an overseas vaccine ... will improve Biologics' overall profitability." The shakeup in the AI space has spread waves across the stock market. Here’s what investors ...

MSD has expanded its presence in Ireland with an agreement to buy a vaccine manufacturing facility from Chinese biotech WuXi Biologics for around €500 million (around $520 million). The plant in ...

WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop ...

WuXi Biologics' CEO Chris Chen has denied that the company’s sale of its less than four-year-old Ireland site is due to the threat of the US Biosecure Act, and said that the number of new ...

Chinese electric-car maker Li Auto and pharmaceutical company WuXi Apptec will join the Hang ... a Hong Kong-based artificial intelligence (AI) biotechnology company, hopes to add momentum to ...

including WuXi AppTec and WuXi Biologics, as well as BGI Group, MGI and Complete Genomics. In late December, WuXi AppTec announced a deal to sell its U.S. and U.K. cell and gene unit, known as ...